Intestinal and Extraintestinal Cancers Associated With Inflammatory Bowel Disease

Podolsky, 2002, Inflammatory bowel disease, N Engl J Med, 347, 417, 10.1056/NEJMra020831 Molodecky, 2012, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology, 142, 46, 10.1053/j.gastro.2011.10.001 Jess, 2013, Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010, Clin Gastroenterol Hepatol, 11, 43, 10.1016/j.cgh.2012.09.026 Nieminen, 2015, Malignancies in inflammatory bowel disease, Scand J Gastroenterol, 50, 81, 10.3109/00365521.2014.992041 Ekbom, 1990, Ulcerative colitis and colorectal cancer: a population-based study, N Engl J Med, 323, 1228, 10.1056/NEJM199011013231802 Beaugerie, 2013, Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease, Gastroenterology, 145, 166, 10.1053/j.gastro.2013.03.044 Bernstein, 2006, The epidemiology of inflammatory bowel disease in Canada: a population-based study, Am J Gastroenterol, 101, 1559, 10.1111/j.1572-0241.2006.00603.x Beaugerie, 2015, Cancers complicating inflammatory bowel disease, N Engl J Med, 372, 1441, 10.1056/NEJMra1403718 Eaden, 2001, The risk of colorectal cancer in ulcerative colitis: a meta analysis, Gut, 48, 526, 10.1136/gut.48.4.526 Burisch, 2013, The burden of inflammatory bowel disease in Europe, J Crohns Colitis, 7, 322, 10.1016/j.crohns.2013.01.010 Jess, 2012, Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies, Clin Gastroenterol Hepatol, 10, 639, 10.1016/j.cgh.2012.01.010 Broomé, 2006, Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer, Semin Liver Dis, 26, 31, 10.1055/s-2006-933561 Rojas-Feria, 2013, Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver, World J Gastroenterol, 19, 7327, 10.3748/wjg.v19.i42.7327 Annese, 2015, European evidence-based consensus: inflammatory bowel disease and malignancies, J Crohns Colitis, 9, 945, 10.1093/ecco-jcc/jjv141 Matkowskyj, 2013, Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology, Arch Pathol Lab Med, 137, 338, 10.5858/arpa.2012-0086-RA Itzkowitz, 2004, Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation, Am J Physiol Gastrointest Liver Physiol, 287, G7, 10.1152/ajpgi.00079.2004 Rubin, 2013, Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study, Clin Gastroenterol Hepatol, 11, 1601, 10.1016/j.cgh.2013.06.023 Hartnett, 2012, Inflammation, DNA methylation and colitis-associated cancer, Carcinogenesis, 33, 723, 10.1093/carcin/bgs006 Gupta, 2007, Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study, Gastroenterology, 133, 1099, 10.1053/j.gastro.2007.08.001 Scarpa, 2014, Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis, World J Gastroenterol, 20, 6774, 10.3748/wjg.v20.i22.6774 Irrazábal, 2014, The multifaceted role of the intestinal microbiota in colon cancer, Mol Cell, 54, 309, 10.1016/j.molcel.2014.03.039 Abreu, 2014, Gastrointestinal malignancy and the microbiome, Gastroenterology, 146, 1534, 10.1053/j.gastro.2014.01.001 Cannon, 2015, Colorectal neoplasia and inflammatory bowel disease, Surg Clin North Am, 95, 1261, 10.1016/j.suc.2015.08.001 Carbonnel, 2017, Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?, Semin Immunopathol, 39, 327, 10.1007/s00281-016-0613-x Axelrad, 2016, Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment, World J Gastroenterol, 22, 4794, 10.3748/wjg.v22.i20.4794 Penn, 1997, Evaluation of transplant candidates with pre-existing malignancies, Ann Transplant, 2, 14 Beaugerie, 2014, Management of inflammatory bowel disease patients with a cancer history, Curr Drug Targets, 15, 1042, 10.2174/1389450115666140821113330 Bressenot, 2014, Microscopic features of colorectal neoplasia in inflammatory bowel diseases, World J Gastroenterol, 20, 3164, 10.3748/wjg.v20.i12.3164 Vieth, 2015, Current issues in inflammatory bowel disease neoplasia, Histopathology, 66, 37, 10.1111/his.12565 Neumann, 2011, Cancer risk in IBD: how to diagnose and how to manage DALM and ALM, World J Gastroenterol, 17, 3184 Farraye, 2010, AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease, Gastroenterology, 138, 746, 10.1053/j.gastro.2009.12.035 Althumairi, 2016, Inflammatory bowel disease associated neoplasia: a surgeon's perspective, World J Gastroenterol, 22, 961, 10.3748/wjg.v22.i3.961 Galandiuk, 2012, Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis, Gastroenterology, 142, 855, 10.1053/j.gastro.2011.12.004 Bae, 2014, Colon cancer screening and surveillance in inflammatory bowel disease, Clin Endosc, 47, 509, 10.5946/ce.2014.47.6.509 Yu, 2016, Surveillance of patients with inflammatory bowel disease, Best Pract Res Clin Gastroenterol, 30, 949, 10.1016/j.bpg.2016.10.014 Farraye, 2010, AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease, Gastroenterology, 138, 738, 10.1053/j.gastro.2009.12.037 Kornbluth, 2010, Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee, Am J Gastroenterol, 105, 501, 10.1038/ajg.2009.727 Leighton, 2006, ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease, Gastrointest Endosc, 63, 558, 10.1016/j.gie.2006.02.005 Laine, 2015, SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease, Gastroenterology, 148, 639, 10.1053/j.gastro.2015.01.031 Annese, 2013, European evidence based consensus for endoscopy in inflammatory bowel disease, J Crohns Colitis, 7, 982, 10.1016/j.crohns.2013.09.016 Cairns, 2010, Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002), Gut, 59, 666, 10.1136/gut.2009.179804 Rutter, 2004, Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis, Gut, 53, 256, 10.1136/gut.2003.016386 Marion, 2016, Chromoendoscopy is more effective than standard colonoscopy in detecting dysplasia during long-term surveillance of patients with colitis, Clin Gastroenterol Hepatol, 14, 713, 10.1016/j.cgh.2015.11.011 Lang, 2015, Chemoprevention of colorectal cancer, Dig Dis, 33, 58, 10.1159/000366037 Jess, 2005, Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies, Am J Gastroenterol, 100, 2724, 10.1111/j.1572-0241.2005.00287.x Elriz, 2013, Incidence, presentation, and prognosis of small bowel adenocarcinoma in patients with small bowel Crohn's disease: a prospective observational study, Inflamm Bowel Dis, 19, 1823 von Roon, 2007, The risk of cancer in patients with Crohn's disease, Dis Colon Rectum, 50, 839, 10.1007/s10350-006-0848-z Svrcek, 2014, Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular study, Inflamm Bowel Dis, 20, 1584, 10.1097/MIB.0000000000000112 Sokol, 2012, Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease, Inflamm Bowel Dis, 18, 2063, 10.1002/ibd.22889 Wong, 2003, Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas, J Pathol, 201, 312, 10.1002/path.1442 Devon, 2009, Cancer of the anus complicating perianal Crohn's disease, Dis Colon Rectum, 52, 211, 10.1007/DCR.0b013e318197d0ad Horsley-Silva, 2016, An update on cancer risk and surveillance in primary sclerosing cholangitis, Liver Int, 1 Karlsen, 2010, Update on primary sclerosing cholangitis, Dig Liver Dis, 42, 390, 10.1016/j.dld.2010.01.011 Rossi, 2016, Primary sclerosing cholangitis associated with inflammatory bowel disease: an update, Eur J Gastroenterol Hepatol, 28, 123, 10.1097/MEG.0000000000000532 Beaugerie, 2014, Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer, Gut, 63, 1416, 10.1136/gutjnl-2013-305763 Pasternak, 2013, Use of azathioprine and the risk of cancer in inflammatory bowel disease, Am J Epidemiol, 177, 1296, 10.1093/aje/kws375 Pedersen, 2010, Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies, Am J Gastroenterol, 105, 1480, 10.1038/ajg.2009.760 Dohan, 2015, Extra-intestinal malignancies in inflammatory bowel diseases: an update with emphasis on MDCT and MR imaging features, Diagn Interv Imaging, 96, 871, 10.1016/j.diii.2015.02.009 Gutierrez-Dalmau, 2007, Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review, Drugs, 67, 1167, 10.2165/00003495-200767080-00006 Beaugerie, 2009, Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study, Lancet, 374, 1617, 10.1016/S0140-6736(09)61302-7 Kotlyar, 2015, Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis, Clin Gastroenterol Hepatol, 13, 847, 10.1016/j.cgh.2014.05.015 Kotlyar, 2011, A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease, Clin Gastroenterol Hepatol, 9, 36, 10.1016/j.cgh.2010.09.016 Peyrin-Biroulet, 2011, Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease, Gastroenterology, 141, 1621, 10.1053/j.gastro.2011.06.050 Ariyaratnam, 2014, Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis, Am J Gastroenterol, 109, 163, 10.1038/ajg.2013.451 Long, 2012, Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease, Gastroenterology, 143, 390, 10.1053/j.gastro.2012.05.004 Nyboe Andersen, 2014, Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease, JAMA, 311, 2406, 10.1001/jama.2014.5613 Kane, 2008, Higher incidence of abnormal Pap smears in women with inflammatory bowel disease, Am J Gastroenterol, 103, 631, 10.1111/j.1572-0241.2007.01582.x Allegretti, 2015, Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia/cancer? A meta-analysis, Inflamm Bowel Dis, 21, 1089, 10.1097/MIB.0000000000000338 Lynch, 2015, Milestones of Lynch syndrome: 1895-2015, Nat Rev Cancer, 15, 181, 10.1038/nrc3878 Lynch, 2003, Hereditary colorectal cancer, N Engl J Med, 348, 919, 10.1056/NEJMra012242 Le, 2015, PD-1 Blockade in tumors with mismatch-repair deficiency, N Engl J Med, 372, 2509, 10.1056/NEJMoa1500596